These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7126413)

  • 1. An oral preparation to release drugs in the human colon.
    Dew MJ; Hughes PJ; Lee MG; Evans BK; Rhodes J
    Br J Clin Pharmacol; 1982 Sep; 14(3):405-8. PubMed ID: 7126413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis.
    Dew MJ; Ryder RE; Evans N; Evans BK; Rhodes J
    Br J Clin Pharmacol; 1983 Aug; 16(2):185-7. PubMed ID: 6615691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology to obtain sustained release characteristics of drugs after delivered to the colon.
    Hu Z; Kimura G; Ito Y; Mawatari S; Shimokawa T; Yoshikawa H; Yoshikawa Y; Takada K
    J Drug Target; 1999; 6(6):439-48. PubMed ID: 10937289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
    Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
    J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose-coated hydroxypropylmethylcellulose capsules.
    Tuleu C; Basit AW; Waddington WA; Ell PJ; Newton JM
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1771-9. PubMed ID: 12269970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of dissolution process on systemic availability of drugs delivered by colon delivery system.
    Takaya T; Niwa K; Muraoka M; Ogita I; Nagai N; Yano R; Kimura G; Yoshikawa Y; Yoshikawa H; Takada K
    J Control Release; 1998 Jan; 50(1-3):111-22. PubMed ID: 9685878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation.
    Rachmilewitz D; Karmeli F; Schwartz LW; Simon PL
    Gut; 1992 Jul; 33(7):929-32. PubMed ID: 1353743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal ileum and colon: targeted sites for 5-ASA release.
    Devane J; Mulligan S; Martin M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():300-3. PubMed ID: 1820897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
    Desreumaux P; Ghosh S
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():2-9. PubMed ID: 16939423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.
    Staerk Laursen L; Stokholm M; Bukhave K; Rask-Madsen J; Lauritsen K
    Gut; 1990 Nov; 31(11):1271-6. PubMed ID: 2253912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
    Dew MJ; Ebden P; Kidwai NS; Lee G; Evans BK; Rhodes J
    Br J Clin Pharmacol; 1984 Apr; 17(4):474-6. PubMed ID: 6144318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs.
    Takaya T; Sawada K; Suzuki H; Funaoka A; Matsuda K; Takada K
    J Drug Target; 1997; 4(5):271-6. PubMed ID: 9169983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA; Elshafeey AH; Elsayed I
    Drug Deliv; 2011 Nov; 18(8):620-30. PubMed ID: 22111975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis.
    Mardini HA; Lindsay DC; Deighton CM; Record CO
    Gut; 1987 Sep; 28(9):1084-9. PubMed ID: 3678967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
    Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
    Dull BJ; Salata K; Goldman P
    Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.
    Rasmussen SN; Bondesen S; Hvidberg EF; Hansen SH; Binder V; Halskov S; Flachs H
    Gastroenterology; 1982 Nov; 83(5):1062-70. PubMed ID: 7117789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.
    Brogden RN; Sorkin EM
    Drugs; 1989 Oct; 38(4):500-23. PubMed ID: 2684592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.